The company said its Cannmart subsidiary received the Access to Cannabis for Medical Purposes Regulations license for 'sales only'
Showing 25 of 160
The company discovered an efficient way to infuse aqueous solutions with oil-based extracts, it said.
The lifestyle company also has an upcoming line of cannabinoid products
Trader and market watcher Tim Collins says the deal gives Canopy long-term stability but loses some its thunder compared to stocks like Tilray
Shares of the health sciences company soar sharply in both Canada and New York
Coca-Cola is exploring the idea of cannabis-infused wellness beverages
Australis Capital invests in the cannabis industry, predominantly in the US
The fact remains: all Canadians who work in the cannabis industry do have a chance of receiving a lifetime ban on travel to the US, particularly if they do business in the US. The chances of it happening? Not likely.
Shares of the cannabis e-commerce platform immediately fell on the news
LeanLife delivers high concentration levels of omega-3 as a nutritional additive, it said
James Thompson took over the reins of the Cincinnati-based health and wellness company from his uncle earlier this year
The company said its cannabinoid-based research continues and it aims to help unlock the full potential of cannabinoid pharmaceuticals
Namaste will distribute BlueSky’s range of products, which includes dietary supplements and a pet care line
Crypto companies have formed the Blockchain Association lobbying group to work with US regulators
The cannabis company acquired Agrorpo and sister company Borela in a US$6.2mln cash deal
ICC in Uruguay is an ideal partner for Aurora Cannabis in expansion into South American market
The Canadian cannabis company said it will be the first brand partner for PAX Labs' PAX Era vaporizer
It was the first Canadian company to win a top strain at an international competition with 'BC God Bud'
The biotech will genetically engineer cannabinoids so that Cronos can bring cannabinoid-based products to market with reliability and scalability
Unlike most Canadian operators, CannaRoyalty has opted to direct the bulk of its attention in California
Cronos stock recovers on Friday after saner voices intervened and defended the Canadian cannabis stock from a classic short-selling attack
Revenue came in at around C$5.4mln for the 12 months to end April, compared to around C$2.6mln for 2017 - a 107% increase
One recent milestone was a deal this month with Asterion Cannabis Inc...
The company acquired exclusive rights to distribute and manufacture Pacific Remedy's infused pre-rolls in California
CNBC contributor Peter Najarian will join the board of the cannabis-focused horticulture lighting company